[ad_1]
President Jair Bolsonaro (without a party) defended on Wednesday (2) that he should not be charged with any side effects of a vaccine against Covid-19.
The agent’s speech goes against the contract signed by Fiocruz (Oswaldo Cruz Foundation) for the development of the vaccine at the University of Oxford (England).
In the document, the institution linked to the Ministry of Health undertakes to bear all possible damages resulting from the use and administration of the immunizer in Brazil. The AstraZeneca laboratory, responsible for producing the vaccine, will be exempt from liability, according to the contract.
Upon arriving at the Palacio de la Alvorada, Bolsonaro did not specifically refer to the document signed by Fiocruz, but questioned his followers who were there.
“Let’s suppose [num contrato sobre fornecimento de vacina] the following is written: ‘[as empresas] we release any compensation or liability with possible immediate or future side effects. ‘ So are you going to get this vaccine? “
“I will show you the complete contract. Whoever takes it will know what they are taking and the consequences. If there is a side effect or a problem they already know that they will not charge me. I will be very clear, this is the vaccine,” he added.
A leaf showed in November that the conditions relating to the company’s sanctions and compensation were imposed by the laboratory for the signing of the contract with Fiocruz. The information appears in the opinion of the Federal Prosecutor’s Office with Fiocruz on the agreement made with the public foundation of the federal government.
In September, Fiocruz signed a contract that contemplates the production of 100.4 million doses of the vaccine and the transfer of technology for its production in the national territory.
The vaccine contract also establishes a kind of compensation ceiling by the company, in the event of breach of the contract or in case of any other claim arising out of the contract.
This amount cannot exceed the amounts paid by Fiocruz to AstraZeneca. The federal government opened an extraordinary loan of R $ 1.9 billion to allow the production and acquisition of vaccine doses by Fiocruz.
The foundation’s attorney general, Deolinda Vieira Costa, said in the September 5 document that the discussion of the clauses was “the most controversial and intense point of the negotiation.” However, it was the “only possible option for Fiocruz.”
According to the ruling, Fiocruz’s initial proposal provided for reciprocity in terms of the rights and duties of the parties, but AstraZeneca did not accept it. Still, the contract was signed on September 9.
Despite the disagreement on the final wording of the contract, the Brazilian agency would have accepted the terms “in view of the public interest involved in accessing a product so important to the health of the population.” “Given the factual circumstances, it seems that the negotiation has reached an insurmountable point and that acceptance of the imposition has been the only possible option for Fiocruz,” Costa wrote.
The vaccine developed in Oxford has not yet proven its effectiveness, but it is considered one of the most promising and the main bet of President Jair Bolsonaro for immunization in Brazil.
